XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $261K invested in XTL Biopharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
RhumbLine Advisers
Boston,
Massachusetts
|
$20K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1.52K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$12.6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $227K | 198,888 | – | – |
|
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $20K | 17,261 | +6,307 | +58% |
|
|
3
Morgan Stanley
New York
| $12.6K | 11,011 | -2,240 | -17% |
|
|
4
UBS Group
Zurich,
Switzerland
| $1.52K | 1,336 | +1,336 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| – | – | -25,211 | Closed |
|